Login / Signup
Mikael Elvborn
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 1
Top Topics
Neuroendocrine Tumors
Clinical Trial
Skeletal Muscle
Top Venues
Cancers
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Mikael Elvborn
,
Emman Shubbar
,
Eva Forssell-Aronsson
Hyperfractionated Treatment with 177 Lu-Octreotate Increases Tumor Response in Human Small-Intestine Neuroendocrine GOT1 Tumor Model.
Cancers
14 (1) (2022)